Reiner Frey

1.4k total citations
49 papers, 1.0k citations indexed

About

Reiner Frey is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Reiner Frey has authored 49 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 26 papers in Cardiology and Cardiovascular Medicine and 13 papers in Physiology. Recurrent topics in Reiner Frey's work include Pulmonary Hypertension Research and Treatments (26 papers), Heart Failure Treatment and Management (13 papers) and Nitric Oxide and Endothelin Effects (10 papers). Reiner Frey is often cited by papers focused on Pulmonary Hypertension Research and Treatments (26 papers), Heart Failure Treatment and Management (13 papers) and Nitric Oxide and Endothelin Effects (10 papers). Reiner Frey collaborates with scholars based in Germany, United States and Austria. Reiner Frey's co-authors include Sigrun Unger, Wolfgang Mück, Georg Wensing, Gerrit Weimann, Corina Becker, Soundos Saleh, Wolfgang Mueck, Stephan Rosenkranz, Diana Bonderman and Veselin Mitrović and has published in prestigious journals such as Circulation, CHEST Journal and European Respiratory Journal.

In The Last Decade

Reiner Frey

48 papers receiving 982 citations

Peers

Reiner Frey
Sigrun Unger Germany
Dianne Judd United States
M.F. Frosolono United States
Kang‐Hyeon Choe South Korea
Robert E. Bowden United States
Sigrun Unger Germany
Reiner Frey
Citations per year, relative to Reiner Frey Reiner Frey (= 1×) peers Sigrun Unger

Countries citing papers authored by Reiner Frey

Since Specialization
Citations

This map shows the geographic impact of Reiner Frey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reiner Frey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reiner Frey more than expected).

Fields of papers citing papers by Reiner Frey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reiner Frey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reiner Frey. The network helps show where Reiner Frey may publish in the future.

Co-authorship network of co-authors of Reiner Frey

This figure shows the co-authorship network connecting the top 25 collaborators of Reiner Frey. A scholar is included among the top collaborators of Reiner Frey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reiner Frey. Reiner Frey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hill, Nicholas S., Franck Rahaghi, Namita Sood, Reiner Frey, & Hossein Ardeschir Ghofrani. (2017). Individual dose adjustment of riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Respiratory Medicine. 129. 124–129. 11 indexed citations
2.
Saleh, Soundos, Corina Becker, Reiner Frey, & Wolfgang Mück. (2016). Population Pharmacokinetics and the Pharmacokinetic/Pharmacodynamic Relationship of Riociguat in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension. Pulmonary Circulation. 6(S1). S86–96. 13 indexed citations
3.
Frey, Reiner, Michaël Reber, Jörn Krätzschmar, et al.. (2016). Riociguat (BAY 63‐2521) and Aspirin: A Randomized, Pharmacodynamic, and Pharmacokinetic Interaction Study. Pulmonary Circulation. 6(S1). S35–42. 11 indexed citations
4.
Becker, Corina, Reiner Frey, Christiane Hesse, et al.. (2016). Absorption of Riociguat (BAY 63‐2521): Bioavailability, Food Effects, and Dose Proportionality. Pulmonary Circulation. 6(S1). S27–34. 12 indexed citations
5.
Saleh, Soundos, Corina Becker, Reiner Frey, & Wolfgang Mück. (2016). Population Pharmacokinetics of Single‐Dose Riociguat in Patients with Renal or Hepatic Impairment. Pulmonary Circulation. 6(S1). S75–85. 12 indexed citations
6.
Becker, Corina, Reiner Frey, Sigrun Unger, et al.. (2016). Pharmacokinetic Interaction of Riociguat with Ketoconazole, Clarithromycin, and Midazolam. Pulmonary Circulation. 6(S1). 24 indexed citations
8.
Frey, Reiner, Corina Becker, Sigrun Unger, et al.. (2016). Assessment of the Effects of Renal Impairment and Smoking on the Pharmacokinetics of a Single Oral Dose of the Soluble Guanylate Cyclase Stimulator Riociguat (BAY 63‐2521). Pulmonary Circulation. 6(S1). S15–26. 22 indexed citations
9.
Frey, Reiner & Wolfgang Mück. (2016). Clinical Implications of Riociguat Pharmacokinetics and Pharmacodynamics: Introduction to the Riociguat Clinical Pharmacology Supplement. Pulmonary Circulation. 6(S1). 3 indexed citations
10.
Becker, Corina, et al.. (2016). Effects of Omeprazole and Aluminum Hydroxide/Magnesium Hydroxide on Riociguat Absorption. Pulmonary Circulation. 6(S1). S43–8. 8 indexed citations
11.
Saleh, Soundos, Reiner Frey, Corina Becker, et al.. (2016). Bioavailability, Pharmacokinetics, and Safety of Riociguat Given as an Oral Suspension or Crushed Tablet with and without Food. Pulmonary Circulation. 6(S1). S66–74. 9 indexed citations
12.
Ghofrani, Hossein Ardeschir, Gerd Staehler, Ekkehard Grünig, et al.. (2015). Acute Effects of Riociguat in Borderline or Manifest Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease. Pulmonary Circulation. 5(2). 296–304. 30 indexed citations
13.
Bonderman, Diana, Ingrid Pretsch, Regina Steringer‐Mascherbauer, et al.. (2014). Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1). CHEST Journal. 146(5). 1274–1285. 198 indexed citations
14.
Becker, Corina, Reiner Frey, Sigrun Unger, et al.. (2013). Pharmacokinetic (PK) interaction of ketoconazole (KC), clarithromycin (CM) and midazolam (MZ) with riociguat. European Respiratory Journal. 42(Suppl 57). P4068–P4068. 1 indexed citations
15.
Ghio, Stefano, Diana Bonderman, Stephan B. Felix, et al.. (2012). Left Ventricular Systolic Dysfunction Associated with Pulmonary Hypertension Riociguat Trial (LEPHT): Rationale and Design. European Journal of Heart Failure. 14(8). 946–953. 21 indexed citations
16.
Lettieri, John, et al.. (2011). Assessment of the Effects of Renal Impairment on the Pharmacokinetics of the Soluble Guanylate Cyclase Activator Cinaciguat After a Single Intravenous Dose. The Journal of Clinical Pharmacology. 52(8). 1240–1247. 3 indexed citations
17.
Frey, Reiner, Wolfgang Mück, Mark Jean Gnoth, et al.. (2011). Pharmacokinetics of the Soluble Guanylate Cyclase Activator Cinaciguat in Individuals With Hepatic Impairment. The Journal of Clinical Pharmacology. 52(11). 1714–1724. 4 indexed citations
18.
Frey, Reiner, et al.. (2010). Riociguat (BAY 63–2521) and Warfarin: A Pharmacodynamic and Pharmacokinetic Interaction Study. The Journal of Clinical Pharmacology. 51(7). 1051–1060. 41 indexed citations
19.
Frey, Reiner, et al.. (2008). Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Activator Cinaciguat (BAY 58‐2667) in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 48(12). 1400–1410. 56 indexed citations
20.
Frey, Reiner. (1983). Kein Weg ins Freie : Joseph Roths Amerikabild. P. Lang eBooks.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026